Effect of folate on neointima formation and matrix metalloproteinase-9 expression after balloon injury in hyperhomocysteinemic rabbits

International Journal of Cardiology

Volumn 131, Issue 1, 2008, Pages 59-65

  Liu, FenYe ^a   Zhang, JiDong ^a   Yu, ShuDong ^b   Wang, Rong ^a   Wang, Bo ^a   Lai, LiPing ^a   Yin, HuiQiu ^a   Liu, Guilin ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Balloon injury; Folate; Matrix metalloproteinase 9; Neointima formation

Indexed keywords

FOLIC ACID; GELATINASE B; HOMOCYSTEINE; MESSENGER RNA; METHIONINE;

ABDOMINAL AORTA; AMINO ACID BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BALLOON INJURY; CELL ULTRASTRUCTURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERHOMOCYSTEINEMIA; INTIMA; MALE; MORPHOMETRICS; NEW ZEALAND; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STOMACH INJURY; THICKNESS; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, ABDOMINAL; BALLOON DILATATION; FOLIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERHOMOCYSTEINEMIA; MALE; MATRIX METALLOPROTEINASE 9; RABBITS; TUNICA INTIMA;

EID: 56349149888     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.08.138     Document Type: Article

References (35)

1. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
2. Kuzuya M., and Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 10 (2003) 275-282
3. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J 315 (1996) 335-342
4. Mason D.P., Kenagy R.D., Hasenstab D., et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85 (1999) 1179-1185
5. Feldman L.J., Mazighi M., Scheuble A., et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 103 (2001) 3117-3122
6. Cedro K., Radomski A., Radomski M.W., Ruzyllo W., and Herbaczynska-Cedro K. Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study. Int J Cardiol 92 (2003) 177-180
7. Cho A., and Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91 (2002) 845-851
8. Galis Z.S., Johnson C., Godin D., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91 (2002) 852-859
9. Malinow M.R., Nieto F.J., Szklo M., Chambless L.E., and Bond G. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The atherosclerosis risk in communities study. Circulation 87 (1993) 1107-1113
10. Morita H., Kurihara H., Kuwaki T., et al. Homocysteine as a risk factor for restenosis after coronary angioplasty. Thromb Haemost 84 (2000) 27-31
11. Schnyder G., Roffi M., Flammer Y., Pin R., and Hess O.M. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur Heart J 23 (2002) 726-733
12. Kojoglanian S.A., Jorgensen M.B., Wolde-Tsadik G., Burchette R.J., and Aharonian V.J. Restenosis in intervened coronaries with hyperhomocysteinemia (RICH). Am Heart J 146 (2003) 1077-1081
13. Morita H., Kurihara H., Yoshida S., et al. Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation 103 (2001) 133-139
14. Smith T.P., Cruz C.P., Brown A.T., Eidt J.F., and Moursi M.M. Folate supplementation inhibits intimal hyperplasia induced by a high-homocysteine diet in a rat carotid endarterectomy model. J Vasc Surg 34 (2001) 474-481
15. Vester B., and Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29 (1991) 549-554
16. - ΔΔCt method. Methods 25 (2001) 402-408
17. Wong C.K., Hammett C.J., The R., et al. Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting. Heart 90 (2004) 1299-1302
18. Breuckmann F., Naber C., Beckert J., et al. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis. Int J Cardiol 108 (2006) 20-25
19. Ambrosi P. Homocysteine and post-angioplasty restenosis. Nutr Metab Cardiovasc Dis 13 (2003) 391-397
20. Lange H., Suryapranata H., De Luca G., et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 350 (2004) 2673-2681
21. Dzau V.J., Braun-Dullaeus R.C., and Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8 (2002) 1249-1256
22. Southgate K.M., Fisher M., Banning A.P., et al. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res 79 (1996) 1177-1187
23. Ge J., Shen C., Liang C., Chen L., Qian J., and Chen H. Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol 112 (2006) 85-90
24. Zempo N., Koyama N., Kenagy R.D., Lea H.J., and Clowes A.W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16 (1996) 28-33
25. Ovechkin A.V., Tyaqi N., Sen U., et al. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Am J Physiol Lung Cell Mol Physiol 291 (2006) L905-L911
26. Shastry S., and Tyagi S.C. Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 93 (2004) 207-213
27. Holven K.B., Halvorsen B., Schulz H., Aukrust P., Ose L., and Nenseter M.S. Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects. Eur J Clin Invest 33 (2003) 555-560
28. Tawakol A., Migrino R.Q., Aziz K.S., et al. High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol 45 (2005) 1580-1584
29. Chambers J.C., Ueland P.M., Obeid O.A., Wrigley J., Refsum H., and Kooner J.S. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102 (2000) 2479-2483
30. Till U., Rohl P., Jentsch A., et al. Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12. Atherosclerosis 181 (2005) 131-135
31. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., and Rabelink T.J. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 97 (1998) 237-241
32. Stroes E.S., van Faassen E.E., Yo M., et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 86 (2000) 1129-1134
33. Li M., Chen J., Li Y.S., Feng Y.B., Gu X., and Shi C.Z. Folic acid reduces adhesion molecules VCAM-1 expression in aortic of rats with hyperhomocysteinemia. Int J Cardiol 106 (2006) 285-288
34. Carmody B.J., Arora S., Avena R., Cosby K., and Sidawy A.N. Folic acid inhibits homocysteine -induced proliferation of human arterial smooth muscle cells. J Vasc Surg 30 (1999) 1121-1128
35. Schnyder G., Roffi M., Pin R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345 (2001) 1593-1600